Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
44.48
+0.37 (0.84%)
May 29, 2025, 2:45 PM CST

Hangzhou Biotest Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
472519.74435.931,8941,811855.9
Upgrade
Other Revenue
39.6739.676.187.237.099.47
Upgrade
Revenue
511.66559.4442.111,9011,818865.37
Upgrade
Revenue Growth (YoY)
7.93%26.53%-76.74%4.57%110.09%314.37%
Upgrade
Cost of Revenue
259.08286.6269.6940.21705.47242.57
Upgrade
Gross Profit
252.58272.81172.51960.931,113622.8
Upgrade
Selling, General & Admin
93.0685.979.2186.0969.6342.36
Upgrade
Research & Development
64.0563.5780.48108.2161.9241.32
Upgrade
Other Operating Expenses
9.587.054.9519.4916.849.69
Upgrade
Operating Expenses
168.9160.05168.31208.2151.6196.6
Upgrade
Operating Income
83.68112.764.21752.73961526.2
Upgrade
Interest Expense
-0.03-0.03-0.14-0.19-0.68-0.47
Upgrade
Interest & Investment Income
50.5457.2876.951.9115.361.4
Upgrade
Currency Exchange Gain (Loss)
11.4411.4413.07111.92-15.48-17.16
Upgrade
Other Non Operating Income (Expenses)
-1.92-1.92-0.59-1.1-0.87-0.67
Upgrade
EBT Excluding Unusual Items
143.71179.5293.46915.26959.34509.3
Upgrade
Gain (Loss) on Sale of Investments
0.270.26-0.060.84-
Upgrade
Gain (Loss) on Sale of Assets
-0.61-0.330---0.03
Upgrade
Asset Writedown
0.34--6.35-18.78-0-0
Upgrade
Other Unusual Items
16.1415.4728.775.358.455.06
Upgrade
Pretax Income
159.85194.92115.88901.9968.63514.33
Upgrade
Income Tax Expense
24.9628.1410.58128.33132.8779.36
Upgrade
Earnings From Continuing Operations
134.89166.78105.3773.56835.76434.97
Upgrade
Minority Interest in Earnings
3.722.741.310.07-2.170.18
Upgrade
Net Income
138.62169.52106.61773.63833.59435.15
Upgrade
Net Income to Common
138.62169.52106.61773.63833.59435.15
Upgrade
Net Income Growth
3.19%59.01%-86.22%-7.19%91.56%1441.52%
Upgrade
Shares Outstanding (Basic)
1071051071078780
Upgrade
Shares Outstanding (Diluted)
1071051071078780
Upgrade
Shares Change (YoY)
0.82%-1.23%-0.10%23.15%8.33%-0.01%
Upgrade
EPS (Basic)
1.301.611.007.259.625.44
Upgrade
EPS (Diluted)
1.301.611.007.259.625.44
Upgrade
EPS Growth
2.34%61.00%-86.21%-24.64%76.84%1454.29%
Upgrade
Free Cash Flow
13.04-116.2374.96524.29707.92388.38
Upgrade
Free Cash Flow Per Share
0.12-1.100.704.918.174.86
Upgrade
Dividend Per Share
1.5001.5000.8002.2003.000-
Upgrade
Dividend Growth
87.50%87.50%-63.64%-26.67%--
Upgrade
Gross Margin
49.36%48.77%39.02%50.54%61.20%71.97%
Upgrade
Operating Margin
16.36%20.16%0.95%39.59%52.86%60.81%
Upgrade
Profit Margin
27.09%30.30%24.11%40.69%45.85%50.28%
Upgrade
Free Cash Flow Margin
2.55%-20.78%16.95%27.58%38.94%44.88%
Upgrade
EBITDA
104.1134.0328.88772.63969.2531.69
Upgrade
EBITDA Margin
20.34%23.96%6.53%40.64%53.31%61.44%
Upgrade
D&A For EBITDA
20.4121.2724.6819.98.25.48
Upgrade
EBIT
83.68112.764.21752.73961526.2
Upgrade
EBIT Margin
16.36%20.16%0.95%39.59%52.86%60.81%
Upgrade
Effective Tax Rate
15.61%14.44%9.13%14.23%13.72%15.43%
Upgrade
Revenue as Reported
511.66559.4442.111,9011,818865.37
Upgrade
Advertising Expenses
-2.824.213.191.632.41
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.